Lori Anne Kunkel Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Lori Anne Kunkel is Director of Nurix Therapeutics, Inc.. Currently has a direct ownership of 0 shares of NRIX, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2024, when has been sold 54,027 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Lori Anne Kunkel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2024
SELL
Bona fide gift
-
54,027 Reduced 100.0%
0 Common Stock

Also insider at

CRIS
CURIS INC Healthcare
Director
ORIC
Oric Pharmaceuticals, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
LAK

Lori Anne Kunkel

Director
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX